|
|
 |
|
Viewing report
|
|
|
|
Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review
GlobalData, April 2012, Pages: 45
Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review
Summary
Actelion Ltd (Actelion) is a Switzerland based biopharmaceutical company. The company discovers, develops and commercializes innovative treatments which serve high unmet medical needs. Actelion was a pioneer in development of endothelin receptor antagonists. The major products of the company include Tracleer, Ventavis, Veletri (Epoprostenol for Injection) and Zavesca. Geographically, the company operates through its subsidiaries in over 30 countries across the world including London, the US, Canada, Israel, Brazil, Korea, China, Japan, France and Germany.
The key business strategies of the company include enhanced focus on achieving flexibility and optimum operational efficiency in its discovery and development process to cater to diverse needs of its clients in an efficient manner. It also focuses on emerging international markets to fuel its growth prospects in future which also helps it to tap the immense market potential in the pharmaceutical and healthcare market domain. The company also aims to maintain its existing partnerships and to enter new collaborative agreements to fuel its services. Actelion is headquartered in Allschwil, Switzerland.
Actelion Ltd Key Recent Developments
Apr 02, 2012: Actelion Provides Update On CRTH2 Program
Feb 14, 2012: Actelion Reports Revenue Of CHF424.4m In Q4 2011
Nov 21, 2011: Actelion To Appeal Verdict In Asahi Kasei Litigation
Oct 24, 2011: Actelion Provides Update On Judgment In Asahi Kasei Litigation
Oct 20, 2011: Actelion Reports Net Revenue Of CHF401.8m In Q3 2011
This comprehensive SWOT profile of Actelion Ltd provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Asahi Kasei Corporation (3407) - Financial and Strategic SWOT Analysis Review
Asahi Kasei Corporation Petrochemicals Capacity and SWOT Analysis
Asahi Kasei Corporation - Strategy and SWOT Report
Actelion Ltd - Product Pipeline Review - Q2 2011
Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review
Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review
GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review
Auxilium Pharmaceuticals, Inc. (AUXL) - Financial and Strategic SWOT Analysis Review
Actelion Ltd - Product Pipeline Review - H2 2011
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
|
|
|
|
